Home / Resource Library / Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma – a retrospective multicenter analysis

Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma – a retrospective multicenter analysis

Results of a study investigating brentuximab vedotin with radiation therapy for treatment of CTCL.